Barth syndrome

Advertisement

cGxPJobs Banner

Stealth BioTherapeutics Expands Access with Mito Assist™ and AnovoRx Partnership

NEEDHAM, Mass., October 9, 2025 — Stealth BioTherapeutics Inc. has announced the launch of Mito Assist™, a comprehensive patient...

By cGxPwire Editor
October 9, 2025

Read More

FDA Accelerates First-Ever Barth Syndrome Therapy, FORZINITY™

NEEDHAM, Mass., September 19, 2025 – Stealth BioTherapeutics Inc. today announced that the U.S. Food and Drug Administration (FDA)...

By cGxPwire Editor
September 22, 2025

Read More

Advertisement

cGxPJobs

Directory